MAZE
Maze Therapeutics, Inc.Company with tickers: MAZE
Market Cap
$1.57B
Shares Outstanding
55,345,261
CIK
1842295
CUSIP
578784100
Investor Relations
Investor relations
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
19
Net buyers
-4
Net shares bought
-0.20%
Net buy value
-$2,969,337
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-23 | Coloma Jason V |
Director, Chief Executive Officer | Sell | 23,865 |
| 2026-06-22 | Coloma Jason V |
Director, Chief Executive Officer | Sell | 1,953 |
| 2026-06-22 | Coloma Jason V |
Director, Chief Executive Officer | Sell | 2,040 |
| 2026-06-08 | Lim Jonathan E |
Director | Award | 18,000 |
| 2026-06-08 | SPIEGELMAN DANIEL K |
Director | Award | 18,000 |
| 2026-06-08 | Andrews Nancy C |
Director | Award | 18,000 |
| 2026-06-08 | HOMCY CHARLES J |
Director | Award | 18,000 |
| 2026-06-08 | Hoppenot Herve |
Director | Award | 18,000 |
| 2026-06-08 | SCHELLER RICHARD H |
Director | Award | 18,000 |
| 2026-06-01 | Bernstein Harold |
President, R&D & CMO | Sell | 13,253 |
| 2026-06-01 | Bernstein Harold |
President, R&D & CMO | Sell | 1,600 |
| 2026-06-01 | Coloma Jason V |
Director, Chief Executive Officer | Sell | 6,090 |
| 2026-06-01 | Coloma Jason V |
Director, Chief Executive Officer | Sell | 553 |
| 2026-06-01 | Bernstein Harold |
President, R&D & CMO | Convert | 14,853 |
| 2026-06-01 | Bernstein Harold |
President, R&D & CMO | Convert | 14,853 |
| 2026-05-29 | Dandekar Atul |
CSBO | Sell | 7,500 |
| 2026-05-29 | Dandekar Atul |
CSBO | Convert | 7,500 |
| 2026-05-29 | Dandekar Atul |
CSBO | Convert | 7,500 |
| 2026-05-26 | Coloma Jason V |
Director, Chief Executive Officer | Sell | 25,582 |
| 2026-05-22 | Coloma Jason V |
Director, Chief Executive Officer | Sell | 4,504 |
| 2026-05-22 | Coloma Jason V |
Director, Chief Executive Officer | Sell | 2,478 |
| 2026-05-15 | Coloma Jason V |
Director, Chief Executive Officer | Sell | 1,822 |
| 2026-05-15 | Coloma Jason V |
Director, Chief Executive Officer | Sell | 116 |
| 2026-05-14 | Bernstein Harold |
President, R&D & CMO | Convert | 15,000 |
| 2026-05-14 | Bernstein Harold |
President, R&D & CMO | Sell | 15,000 |
| 2026-05-14 | Bernstein Harold |
President, R&D & CMO | Convert | 15,000 |
| 2026-05-04 | Dandekar Atul |
CSBO | Convert | 8,320 |
| 2026-05-04 | Dandekar Atul |
CSBO | Convert | 5,985 |
| 2026-05-04 | Dandekar Atul |
CSBO | Convert | 5,985 |
| 2026-05-04 | Dandekar Atul |
CSBO | Convert | 8,320 |
| 2026-05-04 | HOMCY CHARLES J |
Director | Gift | 7,422 |
| 2026-04-29 | Dandekar Atul |
CSBO | Convert | 7,500 |
| 2026-04-29 | Dandekar Atul |
CSBO | Convert | 7,500 |
| 2026-04-29 | Dandekar Atul |
CSBO | Sell | 7,500 |
| 2026-04-01 | Bachrodt Amy |
SVP, Finance | Convert | 2,500 |
| 2026-04-01 | Bernstein Harold |
President, R&D & CMO | Sell | 300 |
| 2026-04-01 | Bachrodt Amy |
SVP, Finance | Convert | 2,500 |
| 2026-04-01 | Bernstein Harold |
President, R&D & CMO | Convert | 15,000 |
| 2026-04-01 | Bernstein Harold |
President, R&D & CMO | Sell | 3,348 |
| 2026-04-01 | Bachrodt Amy |
SVP, Finance | Sell | 2,200 |
| 2026-04-01 | Bernstein Harold |
President, R&D & CMO | Sell | 11,352 |
| 2026-04-01 | Bernstein Harold |
President, R&D & CMO | Convert | 15,000 |
| 2026-04-01 | Bachrodt Amy |
SVP, Finance | Sell | 300 |
| 2026-03-30 | Dandekar Atul |
CSBO | Convert | 7,500 |
| 2026-03-30 | Dandekar Atul |
CSBO | Sell | 6,710 |
| 2026-03-30 | Dandekar Atul |
CSBO | Convert | 7,500 |
| 2026-03-30 | Dandekar Atul |
CSBO | Sell | 790 |
| 2026-03-27 | Kumar Neil |
Director | Other | 0 |
| 2026-03-27 | Kumar Neil |
Director | Award | 33,417 |
| 2026-03-20 | Bernstein Harold |
President, R&D & CMO | Convert | 15,000 |
Showing 1–50 of 200 transactions